Sofosbuvir in combination with daclatasvir or simeprevir for 12 weeks in noncirrhotic subjects chronically infected with hepatitis C virus genotype 1: a randomized clinical trial

Pott-Junior, H. ; Bricks, G. ; Grandi, G. ; Figueiredo Senise, J. ; Castelo Filho, A.

Clinical microbiology and infection, 2019-03, Vol.25 (3), p.365-371 [Periódico revisado por pares]

England: Elsevier Ltd

Sem texto completo